Open Free Zero Brokerage Demat Account
+91
T&C and privacy policy

Concord Biotech Ltd IPO

  • Min. Investment14100/ 20 Shares
  • Min. Quantity20
  • Price Range₹705 - ₹741
  • Date Range04 Aug 23 - 08 Aug 23
  Retail Investor can invest upto Rs 2,00,000 in IPO
Dates
  • Application Start Date04 Aug 2023
  • Application End Date08 Aug 2023
  • Allotment begins
  • Refund Initiation Date14 Aug 2023
  • Allotment Date11 Aug 2023
  • Listing On Exchange18 Aug 2023
Registrar Information
  • NameLink Intime India Pvt Ltd
  • Contact no.+91 22 4918 6200
  • Email ID
Company Information

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Financial information

Here’s the consolidated financial information for the last three years:

Particulars FY21 FY22 FY23
(Rs Crore)
Revenue 616.94 712.93 853.17
Net Profit 235.33 178.57 238.13
Total Assets 1183.44 1315.4 1516.83
Strengths
  • Established presence across the complex fermentation value chain;
  • Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas;
  • Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities;
  • Diversified global customer base with long-standing relationships with key customers;
  • Experienced Promoters, management team supported by marquee investors;
Risks
  • Any delay, interruption or reduction in the supply of its raw materials or the transportation of the company raw materials or products may adversely impact the pricing and supply of its products and have an adverse effect on its business.
  • Any manufacturing or quality control issues may damage its reputation, subject it to regulatory action, and expose the company to litigation or other liabilities, which could adversely affect its business, financial condition and results of operations.
  • A slowdown or shutdown in its manufacturing or research and development operations, all located in Gujarat, India, could adversely affect the company business, financial condition and results of operations.
  • The company depends on a limited number of key customers for a substantial portion of its revenues. Any significant reduction in demand for the company products from such customers may adversely affect its business and results of operations.
  • If the company is unable to obtain trademarks and patents for its products or protect such proprietary information, or inadvertently infringe on the patents of others, its business may be adversely affected.
Opportunities
  • Continue to increase our API market share and further develop its portfolio of complex and niche APIs with high growth potential.
  • Increase the presence of its existing formulations and expand into new formulations.
  • Improve cost management and operational efficiencies.
  • Grow its CDMO business.
  • Continue to increase our API market share and further develop its portfolio of complex and niche APIs with high growth potential.
What is Pre Apply?

Pre Apply will allow you to apply for an IPO 1-3 days before the bidding period starts. You'll get the UPI payment mandate once the IPO is open.

Learn more about Pre applying
How to Apply?

Select the IPO you want to apply for from the list of open issues. Enter your correct UPI ID and select the investor type. The quantity should be a multiple of the lot size. If you wish to apply at the cut-off price, simply click on the checkbox next to ’Cut-off price’. You will receive an SMS from the NPCI confirming your bid and requesting you to accept the mandate on your UPI app. We have noticed a significant delay in UPI payment SMS/notifications from NPCI. Request you to be patient. Please ignore this message if you’ve accepted the mandate

How to check your IPO allocation status

Tarsons Products allotment status will be available on or around 23 November 2021. The allotted shares will be credited to the demat account by 25 November 2021. We will provide you with the link to check the allocation’s status as soon as the registrar makes it live. This may happen after the IPO is closed (after 17 November 2021).

Power your investments with our smart trading platforms

  • 8 million+
    App downloads
  • 4 Star
    Rated APP
  • 1-Click
    Order Placement
  • 1,316 Crore+
    Average Daily Turnover